Bellerophon Therapeutics (NSDQ:BLPH) said yesterday that it priced an underwritten public offering of 10,000,000 shares of its common stock at 70¢ apiece.
The Warren, N.J.-based company also gave underwriters a 45-day option to buy an additional 1,500,000 shares of common stock at the same price. Bellerophon expects to reel in roughly $7 million in proceeds from the offering.
Get the full story at our sister site, Drug Delivery Business News.
The post Bellerophon prices $7m offering appeared first on MassDevice.
from MassDevice http://bit.ly/2MsXZKA
Cap comentari:
Publica un comentari a l'entrada